FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W166243463> ?p ?o ?g. }

• W166243463 endingPage "6" @default.
• W166243463 startingPage "71" @default.
• W166243463 abstract "To investigate the overall survival (OS) of patients developing breast cancer (BC) after curative chemotherapy for non-Hodgkin's lymphoma (NHL) and to evaluate the possible effect on the patients' outcome of the expression of drug resistance-related proteins (P-glycoprotein-Pgp, multidrug resistance-associated protein-MRP, and multidrug resistance-related vault lung resistance protein-LRP) in BC issue.25 female patients (median age 60 years, range 37-70) who developed BC after chemotherapy for high/intermediate grade B-cell NHL, treated with CHOP and achieving complete remission (CR). This group was further subdivided in subgroups A and B, according to the time interval between NHL and BC development (</=24 and > 24 months, respectively). A matched-pair group of de novo BC patients formed the control group. BC tissue was immuno-histochemically stained for Pgp, MRP and LRP.The median interval between NHL diagnosis and BC development was 26 months (range 9-49). In both groups 14 patients had tumor grade II; 16 were negative for steroid receptors; 17 overexpressed c-erbB-2; 14 were stage IIIA/B, and 11 stage IV. CMF or CNF (mitoxantrone instead of doxorubicin) were given for BC. Early progression was noticed in all study group patients for which second-line chemotherapy was instituted. There was a better response for stage IV patients in the control versus the study group (p=0.07). More prolonged OS was demonstrate for patients with stage III in the control group (median 51 months) and in subgroup B (median 47 months) than in subgroup A (median 16 months; p=0.00012), as well as for patients with advanced disease (p=0.0045). Development of BC < 24 months after NHL resulted in reduced OS (p=0.017). No difference was noticed in the expression of drug resistance proteins between the study and control group or between subgroups A and B.BC developing shortly after a CR to NHL is an aggressive disease variant with minimal potential for response to conventional chemotherapy. Analysis of Pgp, MRP and LRP failed to demonstrate significant difference between the study and control group, although indications exist that drug resistance mechanisms might be part of the aggressive disease phenotype, contributing to the poor outcome." @default.
• W166243463 created "2016-06-24" @default.
• W166243463 creator A5000998189 @default.
• W166243463 creator A5002948558 @default.
• W166243463 creator A5017552760 @default.
• W166243463 creator A5035246805 @default.
• W166243463 creator A5037606388 @default.
• W166243463 creator A5037968008 @default.
• W166243463 creator A5069756772 @default.
• W166243463 creator A5077569000 @default.
• W166243463 creator A5077706957 @default.
• W166243463 creator A5084714177 @default.
• W166243463 creator A5085380857 @default.
• W166243463 date "2007-03-06" @default.
• W166243463 modified "2023-09-25" @default.
• W166243463 title "Breast cancer following curative chemotherapy for non-Hodgkin's lymphoma and the effect of drug resistance proteins to the final outcome. A retrospective study." @default.
• W166243463 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17335134" @default.
• W166243463 hasPublicationYear "2007" @default.
• W166243463 type Work @default.
• W166243463 sameAs 166243463 @default.
• W166243463 citedByCount "2" @default.
• W166243463 countsByYear W1662434632015 @default.
• W166243463 crossrefType "journal-article" @default.
• W166243463 hasAuthorship W166243463A5000998189 @default.
• W166243463 hasAuthorship W166243463A5002948558 @default.
• W166243463 hasAuthorship W166243463A5017552760 @default.
• W166243463 hasAuthorship W166243463A5035246805 @default.
• W166243463 hasAuthorship W166243463A5037606388 @default.
• W166243463 hasAuthorship W166243463A5037968008 @default.
• W166243463 hasAuthorship W166243463A5069756772 @default.
• W166243463 hasAuthorship W166243463A5077569000 @default.
• W166243463 hasAuthorship W166243463A5077706957 @default.
• W166243463 hasAuthorship W166243463A5084714177 @default.
• W166243463 hasAuthorship W166243463A5085380857 @default.
• W166243463 hasConcept C114851261 @default.
• W166243463 hasConcept C121608353 @default.
• W166243463 hasConcept C126322002 @default.
• W166243463 hasConcept C143998085 @default.
• W166243463 hasConcept C146357865 @default.
• W166243463 hasConcept C151730666 @default.
• W166243463 hasConcept C2776694085 @default.
• W166243463 hasConcept C2779338263 @default.
• W166243463 hasConcept C2779725641 @default.
• W166243463 hasConcept C2780923524 @default.
• W166243463 hasConcept C2781303535 @default.
• W166243463 hasConcept C530470458 @default.
• W166243463 hasConcept C71924100 @default.
• W166243463 hasConcept C86803240 @default.
• W166243463 hasConcept C89423630 @default.
• W166243463 hasConcept C90924648 @default.
• W166243463 hasConceptScore W166243463C114851261 @default.
• W166243463 hasConceptScore W166243463C121608353 @default.
• W166243463 hasConceptScore W166243463C126322002 @default.
• W166243463 hasConceptScore W166243463C143998085 @default.
• W166243463 hasConceptScore W166243463C146357865 @default.
• W166243463 hasConceptScore W166243463C151730666 @default.
• W166243463 hasConceptScore W166243463C2776694085 @default.
• W166243463 hasConceptScore W166243463C2779338263 @default.
• W166243463 hasConceptScore W166243463C2779725641 @default.
• W166243463 hasConceptScore W166243463C2780923524 @default.
• W166243463 hasConceptScore W166243463C2781303535 @default.
• W166243463 hasConceptScore W166243463C530470458 @default.
• W166243463 hasConceptScore W166243463C71924100 @default.
• W166243463 hasConceptScore W166243463C86803240 @default.
• W166243463 hasConceptScore W166243463C89423630 @default.
• W166243463 hasConceptScore W166243463C90924648 @default.
• W166243463 hasIssue "1" @default.
• W166243463 hasLocation W1662434631 @default.
• W166243463 hasOpenAccess W166243463 @default.
• W166243463 hasPrimaryLocation W1662434631 @default.
• W166243463 hasRelatedWork W2170331034 @default.
• W166243463 hasVolume "10" @default.
• W166243463 isParatext "false" @default.
• W166243463 isRetracted "false" @default.
• W166243463 magId "166243463" @default.
• W166243463 workType "article" @default.